Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and ...

A couple drops in your eye usually brings relief, not concern—but a rare recall case highlights the importance of a clean, sterile bottle.

Novartis’ long-awaited separation from its eye care division Alcon completed on schedule today, allowing it to focus its energies on medicinal products. Alcon’s shares made their debut on the ...

KeyBanc analyst Brett Fishbin revised the price target for Alcon Inc. (NYSE: NYSE:ALC) to $105.00, down from the previous target of $107.00, while continuing to endorse the stock with an Overweight ...